Gilead Sciences, Inc. (GILD) — Stock Price, Chart & Analysis
Gilead Sciences, Inc. (GILD) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $189.30B. Over the past 52 weeks, GILD has traded between $108.46 and $157.29. Gilead Sciences, Inc. pays a dividend yielding 2.2%. View the live GILD chart, technical opinion, analyst ratings, fundamentals and latest news below.
Gilead Sciences, Inc. (GILD) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $189.30B |
| EPS (TTM) | $-2.69 |
| Dividend yield | 2.2% |
| 52-week high | $157.29 |
| 52-week low | $108.46 |
| Beta | 0.35 |
| Avg. volume | 6.69M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently asked questions about Gilead Sciences, Inc. (GILD)
How much does one share of Gilead Sciences, Inc. cost?
As of the latest update, one share of Gilead Sciences, Inc. (GILD) trades at $100 (+0.00% today).
What is Gilead Sciences, Inc.'s market cap?
Gilead Sciences, Inc. has a market capitalization of approximately $189.30B.
What is Gilead Sciences, Inc.'s earnings per share (EPS)?
Gilead Sciences, Inc.'s trailing twelve-month EPS is $-2.69.
Does Gilead Sciences, Inc. pay a dividend?
Yes — Gilead Sciences, Inc. pays a dividend with a yield of 2.2% ($3.28 per share annually).
What is Gilead Sciences, Inc.'s 52-week trading range?
Over the past year, GILD has traded between $108.46 and $157.29.
What is the analyst price target for Gilead Sciences, Inc.?
The mean analyst price target for Gilead Sciences, Inc. is $158.15. This is informational only and not investment advice.
Latest Gilead Sciences, Inc. (GILD) news
- Gilead Sciences (GILD) Stock Moves 1.40%: What You Should KnowNews · Sep 22, 2026
- 1 Cash-Producing Stock on Our Buy List and 2 We Find RiskyNews · Sep 22, 2026
- Why Morgan Stanley likes Gilead's HIV prevention playNews · Sep 20, 2026
- Why Is Gilead Sciences (GILD) Widening Lenacapavir Access Across 120 Countries?News · Sep 20, 2026
- Gilead Strengthens HIV Growth Platform with Expanded Latin America AccessNews · Sep 18, 2026
- Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHFNews · Sep 17, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live GILD dashboard…